My watch list
my.bionity.com  
Login  

MagForce Nanotechnologies



MagForce Nanotechnologies AG is a German biotechnology company focusing on cancer treatment. It is a world's leading company in treating cancer cells with nanotechnology-based therapy. The company is led by CEO Andreas Jordan.

The method

MagForce has patented a new approach in which magnetizing nano-sized iron particles covered with sugar are led into body part containing cancer cells. Abnormal and quickly expanding cancer cells need a lot more energy than normal cells and thus they swallow sugar-coated nanoparticles unlike healthy cells. After that the body part is subjected to a magnetic field which heats up the nanoparticles up to 70 degrees Celsius and later burns ja kills the cancer cells.

This new method has been tested on animals and also on humans. The first results are promising.

Recognitions and Awards

  • MagForce was named as one of the 10 most promising technologies at the German Future Awards in 2006. [1]

References

  1. ^ MagForce Nanotechnology-Based Cancer Therapy - One of the Ten Most Promising Technologies at the German Future Award 2006
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "MagForce_Nanotechnologies". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE